European Archives - Page 1026 of 1071 - European Medical Journal

EMJ Cardiology 3 [Suppl 1] 2015

The satelite symposium was held in two separate sessions – the first a traditional symposium format, and the second as an interactive panel discussion in which the faculty answered questions from the delegates.

EMJ

Antibiotic and Diuretic Can Form Dangerous Drug Duo in Elderly

SUDDEN death in older patients is twice as likely through the combination of the antibiotic trimethoprim-sulfamethoxazole and the diuretic spironolactone…

EMJ

Personalised Medicine Methods Bolster Prostate Cancer Screening

OPTIMISATION of the prostate-specific antigen (PSA) test has been earmarked through the utilisation of methods from personalised medicine…

EMJ

Big Ben, Covent Garden, and the Thames: Lessons Learned from a Visit to London—Collaboration Improves Outcomes

This past week I have had the honour and pleasure of introducing my book Women and Cardiovascular Disease in London. During the book-signing event, I was…

EMJ

Gilead Announces SVR12 Rates from Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily…

EMJ

Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48week results from two Phase 3 studies (Studies 104 and 111)…

EMJ

Living with a Rare Cancer

Lugano, 25 February 2015 – Within the “umbrella” of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an…

Editor’s Pick: State of the Art of Aortic Valve Implantation: Indications, Outcomes, and Controversies

During the last decade, transcatheter aortic valve implantation (TAVI) has become a revolution in the treatment of high-risk severe aortic stenosis (AS).

Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France

The objective was to calculate the cost-effectiveness profile of STENTYS compared to conventional bare and drug-eluting stents (DES).

Left Ventricular Cardiomyopathy in Mitral Valve Prolapse: Fact or Fiction?

In most patients with mitral valve prolapse (MVP) without severe mitral regurgitation (MR), left ventricular (LV) function is preserved.